74.48 0.00 (0.00%)
After hours: 4:28PM EDT
|Bid||74.46 x 1200|
|Ask||74.47 x 800|
|Day's Range||74.14 - 76.14|
|52 Week Range||48.78 - 76.47|
|Beta (3Y Monthly)||0.85|
|PE Ratio (TTM)||38.81|
|Earnings Date||Jul 24, 2019|
|Forward Dividend & Yield||0.72 (0.95%)|
|1y Target Est||71.39|
Todd Ahlsten, a Barron’s Roundtable panelist and lead portfolio manager of the Parnassus Core Equity fund at Parnassus Investments, sees a rally coming for beaten-up chip stock Nvidia
Cerner Corporation (CERN) today announced it will release its second quarter 2019 earnings results after the market closes Wednesday, July 24. On the call, Cerner will discuss its results and outlook and answer questions from the investment community. An audio webcast will be available live and archived on Cerner’s website in the Investor Relations section.
Cerner Corp NASDAQ/NGS:CERNView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low and declining * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for CERN with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on June 19. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $3.66 billion over the last one-month into ETFs that hold CERN are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
An executive with more than 20 years of experience in health care, including nearly 10 years in executive HR roles at Medtronic, will join Cerner as its new chief human resources officer. She succeeds Julie Wilson, who spent 16 of her 24 years with Cerner in the role of chief people officer, leading the company's dramatic hiring efforts.
Cerner (CERN), a global health platform and innovation company, announced today that Tracy Platt will join the company as its new Executive Vice President and Chief Human Resources Officer. Platt has more than 20 years of experience and joins Cerner after spending nearly 10 years in executive HR roles at Medtronic, a global health care giant that develops and distributes medical devices.
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
Walgreens Boots' (WBA) Retail Pharmacy USA division gains traction from comparable prescription volume growth and a sturdy retail prescription market.
This long-range strategy will aid Boston Scientific (BSX) to deliver a solid financial footing across its MedSurg, Rhythm and Neuro plus Cardiovascular segments.
Teleflex (TFX) issued a statement saying consumers who own the tampered product should immediately discontinue use and return all affected products.
The contribution from new products is substantial to bolster top-line growth during the first half of fiscal 2019 at Hill-Rom (HRC).
GNC Holdings (GNC) continues to witness investors' confidence, courtesy of a few positive factors like strategic new partnerships.
IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.
The acquisition of SuperSonic Imagine is in sync with Hologic's (HOLX) strategy to provide wide-ranging screening, interventional and surgical solutions.
Introduction of multiple products within the Spinal Hardware, balanced revenue growth across key operating segments and robust international sales perk up NuVasive's (NUVA) share price.
This impending divestment remains integral to Haemonetics' (HAE) asset optimization strategy that aims at improving its operational performance and focusing on core competencies.